Antibiotic prescribing for children with upper respiratory tract infection: a Finnish nationwide 7-year observational

Matti Korppi1, Paula Heikkilä1, Sauli Palmu1

  • 1Department of Pediatrics, Tampere University Hospital, and Center for Child, Adolescent and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Arvo Ylpönkatu 34 (ARVO B235), 33014, Tampere, Finland.

Insights

Antibiotic prescriptions for childhood upper respiratory tract infections (URTIs) significantly decreased from 2014 to 2020. However, nearly 9% of children still received unnecessary antibiotics, highlighting the need for further interventions.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pharmacology

Background:

  • Upper respiratory tract infection (URTI) is the most common childhood infection.
  • Uncomplicated URTI is a self-limiting viral illness; antibiotics are not indicated.

Purpose of the Study:

  • To evaluate antibiotic prescribing trends for children with uncomplicated URTI.
  • To assess macrolide prescriptions and associated costs between 2014 and 2020.

Main Methods:

  • Analysis of electronic health records from a large Finnish private clinic network (approx. 250,000 pediatric visits annually).
  • Data included diagnoses, age, visit year, physician specialty, and prescribed antibiotics for children under 18.
  • Focused on 156,187 cases of uncomplicated URTI.

Main Results:

  • Antibiotic prescription rates for uncomplicated URTI decreased from 18.0% in 2014 to 8.8% in 2020.
  • Macrolide prescription rates fell from 6.1% to 1.7% during the study period.
  • Pediatricians prescribed antibiotics less frequently than general practitioners or ENT specialists.

Conclusions:

  • Significant reduction in antibiotic and macrolide prescriptions for uncomplicated URTI observed.
  • Despite reductions, 8.8% of children still received unnecessary antibiotics.
  • Active interventions utilizing EHR systems are needed to further decrease unwarranted antibiotic use.

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...